Your browser doesn't support javascript.
loading
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.
Smith, Kimberly Y; Weinberg, Winkler G; DeJesus, Edwin; Fischl, Margaret A; Liao, Qiming; Ross, Lisa L; Pakes, Gary E; Pappa, Keith A; Lancaster, C Tracey.
Afiliación
  • Smith KY; Section of Infectious Diseases, Rush University Medical Center, Chicago, Illinois, USA.
  • Weinberg WG; Infectious Diseases Service, Kaiser Permanente, Atlanta, Georgia, USA.
  • DeJesus E; Orlando Immunology Center Research Facility, Orlando Immunology Center, Orlando, Florida, USA.
  • Fischl MA; AIDS Clinical Research Unit, University of Miami, Miami, Florida, USA.
  • Liao Q; Infectious Diseases, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
  • Ross LL; Infectious Diseases, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
  • Pakes GE; Infectious Diseases, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
  • Pappa KA; Infectious Diseases, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
  • Lancaster CT; Infectious Diseases, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
AIDS Res Ther ; 5: 5, 2008 Mar 28.
Article en En | MEDLINE | ID: mdl-18373851

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: AIDS Res Ther Año: 2008 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: AIDS Res Ther Año: 2008 Tipo del documento: Article País de afiliación: Estados Unidos